First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BCX7353 in Healthy Western and Japanese Volunteers
Clinical trial NCT02448264 · COMPLETED
Trial details
- NCT number
- NCT02448264
- Sponsor
- BioCryst Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2015-11-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.